Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-089718
Filing Date
2025-06-24
Accepted
2025-06-24 21:33:09
Documents
2
Period of Report
2025-06-23

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 3296
2 EX-24.1 xene-ex24_1.htm EX-24.1 10704
  Complete submission text file 0000950170-25-089718.txt   15382
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address
Cline Darren S (Reporting) CIK: 0001633639 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36687 | Film No.: 251070750